血管通路装置市场按类型、年龄层、最终用户和应用划分 - 全球预测 2025-2032 年

预计到 2032 年，血管通路装置市场规模将达到 93.9 亿美元，复合年增长率为 7.90%。

本文旨在策略性地介绍正在重塑血管通路装置应用和使用方式的临床驱动因素、材料创新以及医疗服务模式的变革。

血管通路装置支援从常规静脉输液到复杂化疗方案和长期居家输液等一系列现代医疗干预措施。随着临床团队将感染预防、病患舒适度和手术效率置于优先地位，装置的选择越来越反映出材料科学、人因工程和医疗服务物流的交叉融合。导管材料和涂层技术的进步，以及手术标准化和血管通路团队模式的建立，正在重塑临床路径和治疗结果。

本导言为製造、临床营运和供应链管理等各相关人员提供了策略背景。医院和门诊医疗机构面临优化器械选择的压力，不仅要确保手术的即时成功，还要考虑导管相关併发症、留置时间和再入院风险等后续指标。同时，分散式医疗模式的兴起使得支援安全居家给药和远端监测的器械变得尤为重要，这就要求製造商考虑器械的耐用性、易插入性和与输液系统的兼容性。

监管审查和支付方关注正在进一步影响产品开发的优先事项，推动产品展现出显着的安全优势和清晰的价值提案。这些临床和竞争因素的综合作用，创造了一种环境，在这种环境下，渐进式的设计改进和整合服务，结合严谨的临床证据和切实可行的营运支持，能够迅速转化为竞争优势。

分析技术创新、临床转型和采购演变，这些因素共同重塑了竞争优势和临床结果。

血管通路领域正经历着一场变革性的转变，其驱动力来自于技术创新、不断变化的医疗环境以及不断发展的临床实践。抗菌和抗血栓涂层的创新，以及先进的聚合物化学技术，正在延长导管的使用寿命并降低感染风险。同时，将设备与相容的传感器和输液泵进行数位化集成，能够为临床医生提供更丰富的术后监测数据和可操作的资讯。

医疗服务向门诊和居家环境的逐步转移，要求医疗设备必须具备用户友好的介面、简化的维护以及与居家输液通讯协定的兼容性。急诊护理人员短缺以及支付方为支持临床优化而采取的奖励，加速了这一转变。血管通路团队的培训和资格认证已成为确保治疗效果一致性的关键，各医疗机构正加大对专业团队的投入，以降低併发症发生率并提高首次穿刺成功率。

医疗服务提供者越来越倾向于选择能够提供临床支援、教育、数据分析等一揽子服务的供应商，而不仅仅是产品供应。法律规范也在不断发展，更加重视上市后监测和真实世界证据，这不仅为製造商提供了证明其产品具有持续临床价值的义务，也带来了相应的机会。总而言之，这些变化共同创造了一个充满活力的市场环境，在这个环境中，市场成功取决于敏捷性、临床伙伴关係以及证据的累积。

对近期关税调整如何改变血管通路供应链的采购、生产布局和筹资策略进行详细评估

关税调整带来的政策环境变化促使血管通路器械产业对整个供应链和筹资策略进行策略性重新评估。製造商和医疗采购商正在调整采购惯例，以应对不断变化的投入成本和贸易动态。这加速了他们实现供应商多元化、探索近岸外包机会以及谈判长期供应商协议的进程，从而使临床营运免受短期价格波动的影响。

为了应对成本压力并保持临床性能，製造商们透过优化生产布局和重新考虑材料选择来应对挑战。一些公司正在投资开发替代聚合物来源，寻求提高灭菌流程效率，并加快自动化进程以降低劳动强度。对于医疗服务提供者而言，合约策略更加重视整体拥有成本和供应商可靠性，他们越来越倾向于寻求以价值为导向的合作模式，以平衡设备价格、临床性能和供应连续性。

采购团队日益采用以场景为基础的库存策略模型，优先保障关键SKU，并在物流供应商之间建立冗余机制。同时，进口医疗设备的监管合规性增加了跨境采购的复杂性，需要格外重视文件记录和品管。这种累积效应既为创新带来了阻力，也激发了创新的奖励。能够在控制投入成本的同时提供临床差异化医疗设备的公司，将在日益严格的贸易环境下更好地满足医疗服务提供者的需求。

透过对产品类型、人口统计特征、最终用户和临床应用进行综合細項分析，挖掘目标产品和服务机会。

细分市场层面的动态变化揭示了临床需求、护理环境和产品性能之间的相互作用，从而驱动不同类型器械和使用者群体的应用模式。按类型划分，市场分析涵盖中央静脉导管和周边血管通路装置，其中周边血管通路装置进一步细分为长外周静脉导管和短外周静脉导管。这种细分至关重要，因为中心静脉装置对于大容量或长期治疗必不可少，而周边装置则更适用于常规的短暂输注。按年龄组别划分，市场分析涵盖成人、老年人和儿童群体，重点强调了针对不同生理差异和护理环境而设计的尺寸、插入技术和安全功能的重要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 抗菌浸渍中央静脉导管的广泛应用可减少血流感染
• 将支援物联网的压力感测器整合到血管通路端口中，用于连续监测血流和数据分析。
• 门诊肿瘤科和输液中心对超音波导引下週边静脉导管的需求不断增长
• 封闭式无针给药转移装置的出现，提高了安全性和遵从性
• 扩大中线导管在家庭医疗保健中用于长期抗生素和营养治疗的应用
• 开发生物可吸收聚合物血管移植物以治疗糖尿病族群的小血管疾病
• 机器人辅助中心静脉置管系统的普及提高了手术精度并减少了手术併发症。
• 提高对采用抗菌屏障技术的无针连接器的监管核准，以降低污染风险

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 血管通路装置市场（依类型划分）

• 中央静脉导管
• 週边血管通路装置
  • 长週边静脉导管
  • 短週边静脉导管

第九章 依年龄组别分類的血管通路装置市场

• 成人
• 老年人
• 孩子们

第十章 依最终用户分類的血管通路装置市场

• 门诊手术中心
• 家庭医疗保健环境
• 医院和诊所

第十一章 血管通路装置市场（依应用领域划分）

• 输血
• 诊断和检测
• 药物管理
  • 静脉注射抗生素
  • 化疗

第十二章 各地区血管通路装置市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 血管通路装置市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国血管通路装置市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • 3M Company
  • Access Vascular, Inc.
  • AMECATH
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cook Medical, Inc.
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Sonosite, Inc.
  • ICU Medical, Inc.
  • Kimal PLC
  • Medical Components, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • Prodimed
  • Semler Technologies Inc.
  • Siemens Healthcare AG
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Versago Vascular Access
  • Vygon SA
  • WL Gore & Associates, Inc

The Vascular Access Device Market is projected to grow by USD 9.39 billion at a CAGR of 7.90% by 2032.

A strategic introduction framing clinical drivers, material innovations, and care-delivery changes that are reshaping vascular access device adoption and use

Vascular access devices underpin a wide range of contemporary healthcare interventions, from routine intravenous therapy to complex chemotherapy regimens and extended home infusions. As clinical teams prioritize infection prevention, patient comfort, and procedural efficiency, device choice increasingly reflects the intersection of material science, human factors engineering, and care-delivery logistics. Advances in catheter materials and coatings, combined with procedural standardization and vascular access team models, are reshaping clinical pathways and care outcomes.

This introduction frames the strategic context for stakeholders across manufacturing, clinical operations, and supply chain management. Hospitals and ambulatory providers face pressure to optimize device selection not only for immediate procedural success but also for downstream metrics such as catheter-related complications, dwell time, and readmission risk. Meanwhile, the shift toward decentralized care models has elevated the importance of devices that support safe home administration and remote monitoring, requiring manufacturers to consider durability, ease of insertion, and compatibility with infusion systems.

Regulatory scrutiny and payer attention further shape product development priorities, encouraging demonstrable safety benefits and clear value propositions. Together, these clinical and commercial drivers create an environment in which incremental design improvements and integrated service offerings can translate quickly into competitive advantage when coupled with rigorous clinical evidence and pragmatic operational support.

An analysis of technological innovations, care-site migration, and procurement evolution that are jointly redefining competitive advantage and clinical outcomes

The vascular access landscape is experiencing transformative shifts driven by technological innovation, changing care settings, and evolving clinical practice. Innovations in antimicrobial and antithrombotic coatings, alongside refined polymer chemistry, are improving catheter longevity and reducing infection risks, while design refinements enhance insertion ergonomics and securement reliability. Simultaneously, digital integration such as device-compatible sensors and infusion pumps is enabling richer post-procedural monitoring and actionable data for clinicians.

Care delivery has shifted proportionally toward outpatient and home settings, prompting devices that prioritize user-friendly interfaces, simplified maintenance, and compatibility with at-home infusion protocols. This transition has been accelerated by workforce constraints in acute care and by payer incentives that support care-site optimization. Training and credentialing for vascular access teams have become central to ensuring consistent outcomes, with institutions investing in specialized teams to reduce complication rates and improve first-attempt success.

Procurement strategies are also adapting: providers increasingly favor vendors offering bundled clinical support, education, and data analytics rather than transactional product supply alone. Regulatory frameworks are evolving to emphasize post-market surveillance and real-world evidence, creating both obligations and opportunities for manufacturers to demonstrate sustained clinical value. Taken together, these shifts create a dynamic environment in which agility, clinical partnership, and evidence generation determine market success.

A detailed assessment of how recent tariff adjustments have reshaped sourcing, manufacturing footprints, and procurement strategies across the vascular access supply chain

The policy environment introduced by tariff changes has prompted a strategic reassessment across supply chains and sourcing strategies within the vascular access device sector. Manufacturers and healthcare purchasers are adapting procurement practices in response to altered input costs and shifting trade dynamics. This has accelerated efforts to diversify supplier bases, explore nearshoring opportunities, and negotiate long-term supplier agreements that insulate clinical operations from episodic price volatility.

Manufacturers have reacted by optimizing production footprints and re-evaluating material choices to manage cost pressure while preserving clinical performance. Some firms have invested in alternative polymer sources, sought efficiencies in sterilization workflows, and accelerated automation to reduce labor intensity. For providers, contracting strategies are emphasizing total cost of ownership and supplier reliability, with greater willingness to engage in value-based arrangements that balance device price against clinical outcomes and supply continuity.

Procurement teams are increasingly modeling scenario-based inventory strategies that prioritize critical SKUs and build redundancy across logistics providers. At the same time, regulatory compliance for imported medical devices demands careful attention to documentation and quality controls, adding complexity to cross-border sourcing. These cumulative effects create both headwinds and incentives for innovation, as companies that can deliver clinically differentiated devices while managing input cost exposure will be better positioned to meet provider needs in a more constrained trade environment.

Comprehensive segmentation analysis connecting device types, age cohorts, end users, and clinical applications to reveal targeted product and service opportunities

Segment-level dynamics reveal where clinical demand, care settings, and product performance intersect to drive adoption patterns across different device types and user populations. Based on Type, the market is studied across Central Venous Catheters and Peripheral Vascular Access Devices, with the Peripheral Vascular Access Devices further delineated into Long Peripheral Intravenous Catheter and Short Peripheral Intravenous Catheter; this differentiation matters because central devices remain essential for high-volume or long-term therapies while peripheral options optimize routine and short-duration infusions. Based on Age Group, the market is studied across Adult, Geriatric, and Pediatric cohorts, which highlights the need for tailored sizing, insertion techniques, and safety features to accommodate physiological differences and care environments.

Based on End User, the market is studied across Ambulatory Surgical Centers, Home Healthcare Settings, and Hospitals & Clinics, revealing distinct procurement priorities and support requirements: ambulatory providers prioritize first-attempt success and throughput, homecare emphasizes device simplicity and remote support, and hospitals balance a broad clinical portfolio with the need for durable, multi-indication devices. Based on Application, the market is studied across Blood Transfusion, Diagnostics & Testing, and Drug Administration, with Drug Administration further segmented into Antibiotic Infusion and Chemotherapy; these application niches drive device selection through differing dwell-time expectations, compatibility with infusion regimens, and risk tolerance for complications.

Across these intersecting segments, manufacturers and clinicians can identify high-value opportunities by aligning product design, training investments, and evidence-generation with the specific clinical workflows and risk profiles of each cohort. For example, pediatric device innovation focuses on minimized lumen size and atraumatic insertion, while home healthcare solutions emphasize securement systems and clear maintenance protocols that reduce the burden on non-clinical caregivers.

Regional intelligence that contrasts clinical adoption patterns, regulatory nuance, and commercial imperatives across the Americas, Europe Middle East Africa, and Asia-Pacific markets

Regional dynamics shape both the pace of technological adoption and the structure of commercial opportunity across jurisdictions. Americas markets often prioritize integrated clinical evidence and reimbursement alignment, with strong institutional demand for devices that demonstrate measurable reductions in hospital-acquired complications. Europe, Middle East & Africa display a heterogeneous landscape where regulatory harmonization efforts coexist with varied procurement models and differing levels of homecare infrastructure, creating pockets of rapid adoption alongside regions that remain price sensitive. Asia-Pacific presents a mix of mature metropolitan centers adopting cutting-edge catheter technologies and large emerging markets where scale, cost-efficiency, and supply resilience drive provider choices.

These regional distinctions imply that commercial approaches must be adapted carefully. In the Americas, investments in clinical trials and health economic dossiers can unlock hospital formulary approvals and contracted placements. In Europe, Middle East & Africa, success often depends on tailored regulatory strategies and partnerships with regional distributors that understand local procurement dynamics. In Asia-Pacific, scalable manufacturing, localized training programs, and flexible pricing that addresses both urban tertiary centers and resource-constrained facilities become central to expanding reach.

Cross-region collaboration and knowledge transfer offer opportunities to accelerate adoption of best practices. Manufacturers that build regional evidence packages and deploy adaptable service models will be better placed to capture heterogeneous demand while supporting consistent safety and quality standards across global care settings.

An evaluation of competitive strategies, partnership models, and innovation pathways that determine which firms will lead in clinical adoption and commercial expansion

Competitive dynamics within the vascular access device arena are defined by a blend of established medtech firms and nimble innovators that bring specialized materials, coatings, and digital integration to market. Leading companies concentrate on broad portfolios that span central and peripheral access solutions while investing in clinical studies, post-market surveillance, and training programs that reinforce their value propositions to hospitals and homecare providers. At the same time, smaller specialists and startups are introducing differentiated technologies such as next-generation antimicrobial treatments, sensor-enabled devices, and minimally invasive insertion systems that address specific clinical pain points.

Partnerships and collaborative models are common as firms seek to combine manufacturing scale with clinical expertise and channel access. Strategic alliances with distributors, infusion service providers, and health systems enable faster market penetration and generate the real-world evidence necessary for broader adoption. Mergers and acquisitions remain a viable route to rapidly expand product catalogs and geographic reach, but disciplined integration and continued investment in R&D are critical to realize expected synergies.

Manufacturers that succeed will balance innovation with operational excellence: they will maintain robust quality systems, ensure regulatory readiness across jurisdictions, and offer comprehensive clinical support that reduces the operational burden on purchasers. Commercially, differentiation will come from demonstrated outcomes, integrated service offerings, and the ability to deliver consistent supply under evolving trade conditions.

Actionable recommendations for executives to synchronize product development, clinical evidence, supply resilience, and go-to-market strategies for durable advantage

Industry leaders should act decisively to align product development, commercial strategy, and operational resilience with the evolving demands of clinicians and care settings. First, prioritize portfolio segmentation that matches devices to end-user needs: develop distinct propositions for hospitals, ambulatory centers, and homecare that account for insertion workflows, maintenance expectations, and training needs. Second, invest in clinical evidence and health economic analyses that quantify safety and operational benefits, enabling stronger formulary positioning and payer engagement.

Third, strengthen supply chain resilience through supplier diversification, selective nearshoring, and inventory risk management to mitigate the effects of trade shifts and tariffs. Fourth, accelerate development of features that support decentralized care, such as simplified securement systems, compatibility with portable infusion pumps, and intuitive maintenance instructions for non-clinical caregivers. Fifth, build service-oriented offerings that bundle devices with training, remote support, and data analytics to lock in longer-term partnerships and create differentiated revenue streams.

Finally, engage proactively with regulatory bodies to streamline approvals and demonstrate commitment to post-market surveillance. Embrace sustainability practices where feasible to meet rising institutional expectations and to lower lifecycle costs. By integrating these priorities into a coordinated strategy, manufacturers and providers can improve patient outcomes while capturing sustainable commercial value.

A transparent description of primary and secondary research methods, stakeholder interviews, and data triangulation techniques used to generate the report's conclusions

The research methodology underpinning this analysis combines primary stakeholder engagement with comprehensive secondary review and structured synthesis to ensure robust, actionable findings. Primary inputs included interviews with clinicians, vascular access nurses, procurement leaders, and device developers to capture frontline perspectives on clinical workflows, unmet needs, and purchasing criteria. These qualitative insights were triangulated with secondary sources including regulatory filings, clinical literature, device labeling, and publicly available guidance from professional societies to validate performance claims and safety considerations.

Supply chain and commercial assessments relied on supplier mapping, patent landscape review, and analysis of distribution models to identify sources of resilience and potential bottlenecks. The approach emphasized cross-validation between clinical feedback and operational data to surface pragmatic recommendations. Where appropriate, case studies were used to illustrate successful deployment models and to extract transferable lessons on training, change management, and evidence generation.

Throughout the process, findings were subjected to iterative expert review and quality assurance to minimize bias and ensure clarity. Limitations include the dynamic nature of regulatory policy and trade environments, which may evolve after data collection; therefore, recommendations emphasize adaptive strategies rather than fixed prescriptions.

A concise synthesizing conclusion that distills strategic imperatives across clinical innovation, supply resilience, and service-driven commercialization

The cumulative evidence paints a clear picture: clinical needs, care-site migration, and supply-chain dynamics are converging to reshape the vascular access device landscape. Device innovation that focuses on safety, ease of use, and compatibility with decentralized care models will find growing demand among hospitals, ambulatory centers, and home healthcare providers. At the same time, commercial success will hinge on the ability to pair product excellence with clinical evidence, robust training, and reliable supply arrangements.

Tariff-induced trade adjustments and regional policy variation add complexity but also create incentives for operational optimization and strategic partnerships. Organizations that proactively invest in differentiated device features, service bundles, and regulatory readiness can reduce procurement friction and accelerate adoption across varied market segments. Clinicians and procurement leaders alike will reward solutions that demonstrably lower complication rates, simplify workflows, and support safe care outside the traditional inpatient setting.

In conclusion, the sector favors companies that combine technological sophistication with practical support models and resilient operations. Those that integrate clinical validation, supply-chain foresight, and targeted regional approaches will be best positioned to capture value while improving patient outcomes across care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of antimicrobial-impregnated central venous catheters to reduce bloodstream infections
• 5.2. Integration of IoT-enabled pressure sensors in vascular access ports for continuous flow monitoring and data analytics
• 5.3. Growing demand for ultrasound-guided peripheral intravenous catheters in outpatient oncology and infusion clinics
• 5.4. Emergence of closed system transfer devices for needleless drug administration to improve safety and compliance
• 5.5. Widening use of midline catheters in home healthcare for prolonged antibiotic and nutrition infusion therapies
• 5.6. Development of bioresorbable polymeric vascular grafts to address small vessel disease in diabetic patient populations
• 5.7. Surge in robotic-assisted insertion systems for central venous access to enhance precision and reduce procedural complications
• 5.8. Increasing regulatory approvals for needle-free connectors with antimicrobial barrier technology to curb contamination risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vascular Access Device Market, by Type

• 8.1. Central Venous Catheters
• 8.2. Peripheral Vascular Access Devices
  • 8.2.1. Long Peripheral Intravenous Catheter
  • 8.2.2. Short Peripheral Intravenous Catheter

9. Vascular Access Device Market, by Age Group

• 9.1. Adult
• 9.2. Geriatric
• 9.3. Pediatric

10. Vascular Access Device Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Home Healthcare Settings
• 10.3. Hospitals & Clinics

11. Vascular Access Device Market, by Application

• 11.1. Blood Transfusion
• 11.2. Diagnostics & Testing
• 11.3. Drug Administration
  • 11.3.1. Antibiotic Infusion
  • 11.3.2. Chemotherapy

12. Vascular Access Device Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Vascular Access Device Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Vascular Access Device Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. 3M Company
  • 15.3.2. Access Vascular, Inc.
  • 15.3.3. AMECATH
  • 15.3.4. AngioDynamics, Inc.
  • 15.3.5. Argon Medical Devices, Inc.
  • 15.3.6. Asahi Kasei Medical Co., Ltd.
  • 15.3.7. B. Braun Melsungen AG
  • 15.3.8. Baxter International Inc.
  • 15.3.9. Becton, Dickinson and Company
  • 15.3.10. Cook Medical, Inc.
  • 15.3.11. Edwards Lifesciences Corporation
  • 15.3.12. Fresenius Medical Care AG & Co. KGaA
  • 15.3.13. Fujifilm Sonosite, Inc.
  • 15.3.14. ICU Medical, Inc.
  • 15.3.15. Kimal PLC
  • 15.3.16. Medical Components, Inc.
  • 15.3.17. Medtronic PLC
  • 15.3.18. Nipro Medical Corporation
  • 15.3.19. Prodimed
  • 15.3.20. Semler Technologies Inc.
  • 15.3.21. Siemens Healthcare AG
  • 15.3.22. Smiths Medical, Inc.
  • 15.3.23. Teleflex Incorporated
  • 15.3.24. Terumo Corporation
  • 15.3.25. Versago Vascular Access
  • 15.3.26. Vygon SA
  • 15.3.27. W. L. Gore & Associates, Inc

LIST OF FIGURES

• FIGURE 1. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. VASCULAR ACCESS DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 110. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 111. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 112. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 113. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 114. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 115. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 116. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 117. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 119. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 120. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 121. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 122. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 123. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 124. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 125. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 126. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 127. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 128. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 129. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 130. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 131. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 132. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 133. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 134. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 135. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 136. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 137. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 140. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 141. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 142. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 143. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 144. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 145. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 146. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 147. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 148. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 149. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 150. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 168. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 179. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 182. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 183. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 184. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 185. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 186. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 187. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 188. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 189. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 190. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 191. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 192. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 193. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 196. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 197. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 198. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 199. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 200. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 201. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 202. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 203. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 204. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 205. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 206. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 207. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 210. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 211. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 212. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 213. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 214. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 215. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 216. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 217. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 218. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 219. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 220. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 223. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 226. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 227. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 228. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 229. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 230. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 231. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 232. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 233. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 234. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 235. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 236. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 237. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 238. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 239. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 240. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 241. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 242. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 243. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 244. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 245. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 246. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 247. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 248. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 249. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 250. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 251. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 254. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 255. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 256. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 257. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 258. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 259. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 262. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 263. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 264. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 265. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 266. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 267. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 268. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 269. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 270. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 271. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 272. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 273. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 274. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 275. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 276. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 277. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 278. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 279. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 280. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 281. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 282. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 283. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 284. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 285. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 286. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 287. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 288. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 289. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 290. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 291. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 292. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 293. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 294. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 295. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 296. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 297. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 298. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 299. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 300. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 301. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 302. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 303. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 304. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 305. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 306. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 307. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 308. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 309. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
• TABLE 310. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
• TABLE 311. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2024 (USD MILLION)
• TABLE 312. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2025-2032 (USD MILLION)
• TABLE 313. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 314. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 315. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 316. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 317. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 318. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 319. UNITED STATES VASCULAR A